Gnosis by Lesaffre unveils new website

Published: 24-Jul-2019
Ingredients Nutraceutical

The website is dedicated to Lynside ProteYn, examining its nutritional composition, performance and more

Gnosis by Lesaffre is raising awareness about Lynside ProteYn with the launch of a new dedicated website. The aim is to give Lynside ProteYn a worldwide platform that would enable the company to spread the word about this innovative range of alternative protein source.

This new website, found at lynside-proteyn.com, dives into the specifics of Lynside ProteYn’s nutritional composition and performance as well as educating about the range's reliable and environmentally friendly manufacturing process. This more formal section is then complemented by information about how this innovative protein source fits a variety of dietary lifestyles and can be an exciting way to add protein to one's diet.

The website also offers recipe suggestions using Lynside ProteYn, and more consumer-focused information can be found by subscribing to the newsletter.

  • Companies:
  • Gnosis by Lesaffre
See more

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

Read more
New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond

Trending Articles

  1. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. Health Canada confirms L. plantarum Rosella can support vaginal health The probiotic strain has been recognised to support a healthy vaginal microflora and assist in reducing the recurrence of vulvovaginal candidiasis
  4. Givaudan to showcase the power of botanicals at Vitafoods Europe The company will exhibit ready-to-consume and ingredient formulations derived from botanicals to bolster immune support, urinary tract health, cognition, relaxation and energy
  5. Kerry Group’s Wellmune supports everyday immune health, study finds The study has highlighted the Wellmune's ability to positively modulate the innate immune system

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond
Ingredients

SAMe holds promise for depression, studies find

Two novel studies have suggested S-Adenosylmethionine (SAMe) could be a beneficial monotherapy for patients with depression
Ingredients

SunWay Biotech and Gnosis by Lesaffre form alliance to launch MenaQ7 Metabolic

The novel product will be aimed at the lucrative vitamin K2 market
Ingredients

Vitamin K2 could be at the heart of a healthy lifestyle

Further evidence highlights the impact of essential nutrients on cardiovascular health, including potential $9.48B a year in healthcare cost savings
Ingredients

Gnosis vitamin K2 scientific advisory committee grows and holds first meeting

The inaugural meeting of the Gnosis K2SAC welcomed new members and focused on the exciting future for K2
Ingredients

Gnosis by Lesaffre launches MenaQ7 Protect

A collaboration between Gnosis and Probiotical creates the first private-label, ready-to-market, immune-support supplement featuring clinically validated MenaQ7 K2
Ingredients

New MenaQ7 K2 cardio study in kidney patients published

TReVasc-HDK Trial examined the efficacy of K2 supplementation in reducing vascular calcification progression in haemodialysis patients, offering new insights on appropriate dosing
Subscribe now